Moderna and Coursera Launch Free Course on mRNA Technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Moderna stock: What could trigger a turnaround over the next 3-6 months?
August 15, 2024 7:00 PM EDTModerna's (NASDAQ: MRNA) recent struggles have left investors wondering what could drive a turnaround in the company's stock over the next few months.
Following a turbulent second-quarter earnings report, which included a significant cut to 2024 sales guidance and a sharp decline in valuation, the focus has shifted to potential near-term catalysts.
According to Evercore ISI analysts, Moderna's story is currently... More
